Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
recruiting267%

Recent Activity

2 active trials
Showing 3 of 3
recruitingnot_applicable

Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults

NCT03665831
recruitingnot_applicable

Deep rTMS for Mild Neurocognitive Disorder in Older Adults

NCT07038798
completednot_applicable

Deep rTMS for Treatment-Resistant Late-life Depression

NCT01860157

Clinical Trials (3)

Showing 3 of 3 trials
NCT03665831Not Applicable

Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults

Recruiting
NCT07038798Not Applicable

Deep rTMS for Mild Neurocognitive Disorder in Older Adults

Recruiting
NCT01860157Not Applicable

Deep rTMS for Treatment-Resistant Late-life Depression

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3